By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Galapagos NV 

Industriepark Mechelen Noord I, Zone L
Generaal De Wittelaan 11 A
Mechelen    B-2800  Belgium
Phone: 32-15-34-29-00 Fax: 32-15-34-29-01



Company News
Galapagos (GLPG.BR) To Present Progress In CF Programs At NACFC 2016 10/27/2016 9:20:17 AM
Galapagos (GLPG.BR) Release: Transparency Notification - FMR LLC Reaches 10% Threshold 10/13/2016 10:11:33 AM
MorphoSys AG And Galapagos (GLPG.BR) Start First-In-Patient Dosing of IL-17C Antibody MOR106 In Atopic Dermatitis 9/29/2016 9:22:32 AM
Galapagos (GLPG.BR) Release: Successful Completion Of Regulatory Consultations To Progress Filgotinib To Phase 3 In Inflammatory Bowel Disease 9/28/2016 1:11:09 PM
Gilead (GILD) Can’t Buy Belgium’s Galapagos (GLPG.BR)—Yet 9/28/2016 5:51:40 AM
Galapagos (GLPG.BR) Release: Endoscopic Improvements With Filgotinib Are Consistent With Clinical Remission Rates In Patients With Crohn's Disease 9/26/2016 9:36:44 AM
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 9/20/2016 9:08:50 AM
Galapagos (GLPG.BR) Release: Orphan Drug Designation In European Union For GLPG1690 In Idiopathic Pulmonary Fibrosis 9/6/2016 2:30:51 PM
Galapagos (GLPG.BR) Release: Finch Filgotinib Phase 3 Program Initiated In Rheumatoid Arthritis 8/23/2016 8:49:34 AM
Galapagos (GLPG.BR) Receives Transparency Notification From Federated 8/1/2016 9:27:33 AM